Detalhe da pesquisa
1.
Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UK.
Infect Dis Ther
; 13(5): 1083-1104, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38656653
2.
Healthy ageing: Herpes zoster infection and the role of zoster vaccination.
NPJ Vaccines
; 8(1): 184, 2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38017011
3.
Proceedings of the expert consensus group meeting on herpes zoster disease burden and prevention in India: An opinion paper.
Hum Vaccin Immunother
; 19(2): 2220608, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293792
4.
Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies.
Hum Vaccin Immunother
; 19(3): 2278362, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37965770
5.
An Analysis of How Herpes Zoster Pain Affects Health-related Quality of Life of Placebo Patients From 3 Randomized Phase III Studies.
Clin J Pain
; 39(8): 386-393, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37166199
6.
Natural History of Herpes Zoster in the Placebo Groups of Three Randomized Phase III Clinical Trials.
Infect Dis Ther
; 11(6): 2265-2277, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322332
7.
Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States.
Hum Vaccin Immunother
; 18(1): 2027196, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35049412
8.
A practitioner's guide to the recombinant zoster vaccine: review of national vaccination recommendations.
Expert Rev Vaccines
; 20(9): 1065-1075, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34311643
9.
An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.
Drug Saf
; 44(12): 1341-1353, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34622421
10.
Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review.
Dermatol Ther (Heidelb)
; 11(4): 1119-1126, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33999370
11.
Ten years of experience with the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (Synflorix) in children.
Expert Rev Vaccines
; 19(3): 247-265, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32195602
12.
Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention.
Expert Rev Vaccines
; 17(7): 619-634, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30028651
13.
Comment on "Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine".
Pharmacoeconomics
; 40(10): 1011-1012, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36163540
14.
Correction to: Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review.
Dermatol Ther (Heidelb)
; 11(4): 1127-1128, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34129208
15.
A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice.
NPJ Vaccines
; 12016.
Artigo
em Inglês
| MEDLINE | ID: mdl-29250436